Clinical Trials Browser

OTHER × HER2-positive Gastric Cancer × 130-nm albumin-bound paclitaxel × Clear all

NCT05070598 2021-10-07

Camrelizumab Combined With Chemotherapy in First-line Treatment of HER2-positive Gastric Cancer

Phase 2 Unknown

Gastrointestinal

HER2-positive Gastric Cancer